dabigatran

Study compares dabigatran to warfarin in treating blood clots

  • Fri, 06/08/2012 - 12:31pm

A study headed by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy twice daily

Pradaxa linked to internal bleeding

EMA recommends updated Pradaxa labels

  • Tue, 05/29/2012 - 2:04pm

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) reported Friday that the number of reported fatal bleedings associated with

Study compares dabigatran to warfarin in VTE treatment

  • Tue, 05/29/2012 - 11:06am

A study conducted primarily by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy

Pages

Brought to you by Spangenberg Shibley & Liber, LLP © 2012